John Lambrick
Conseiller Juridique Général chez RMIT University
Profil
John Lambrick is currently working as the General Counsel at RMIT University.
Previously, he worked as a Non-Executive Director at vivoPharm Pty Ltd.
and as a Partner at Molomby & Molomby.
He completed his graduate degree from the University of Melbourne and his undergraduate degree from Monash University.
Postes actifs de John Lambrick
| Sociétés | Poste | Début |
|---|---|---|
| RMIT University | Conseiller Juridique Général | - |
Anciens postes connus de John Lambrick
| Sociétés | Poste | Fin |
|---|---|---|
| Molomby & Molomby | Corporate Officer/Principal | - |
vivoPharm Pty Ltd.
 vivoPharm Pty Ltd. BiotechnologyHealth Technology vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia. | Directeur/Membre du Conseil | - |
Formation de John Lambrick
| Monash University | Undergraduate Degree |
| University of Melbourne | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
vivoPharm Pty Ltd.
vivoPharm Pty Ltd. BiotechnologyHealth Technology vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia. | Health Technology |
| Molomby & Molomby |